Letter to HFEA on Sex Selection
By Tania Simoncelli and Marcy Darnovsky
| 01. 22. 2003
Vishnee Seenundun
Consultation Co-ordinator
HFEA
Paxton House
30 Artillery Lane
London E1 7LS
Dear Vishnee Seenundun,
We are writing to express our concern regarding the HFEA's
public consultation on sex selection, and to encourage you to
ensure that strong policies are upheld and further developed
against non-medical sex selection.
The Center for Genetics and Society is a U.S.-based non-profit
public interest organization working to encourage responsible
uses and democratic governance of the new human genetic and
reproductive technologies. In our work, we look to the HFEA
as a model for responsible regulation, and consider that your
work carries critical weight for international policy making
well beyond the UK. Conversely, we feel that the HFEA would
do well to consider U.S. experience in this field, where a virtual
absence of regulation has led to a shortchanging of ethical
and social considerations and an unacceptable level of permissiveness
in the fertility industry.
In general, we are concerned by the way in which the consultation
document, "Sex selection: Choice and responsibility in
reproduction" frames the consultation process around "risks
to health" and "reliability...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...
